{
  "resourceType": "RegulatedAuthorization",
  "id": "actavis-pharma-inc-ibuprofen-20-MG-ML-Oral-Suspens-336-USA-RA",
  "meta": {
    "profile": [
      "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
    ]
  },
  "type": {
    "coding": [
      {
        "code": "220000000061",
        "system": "https://spor.ema.europa.eu/v1/lists/220000000060",
        "display": "Marketing Authorisation"
      }
    ]
  },
  "identifier": [
    {
      "value": ""
    }
  ],
  "subject": [
    {
      "reference": "MedicinalProductDefinition/actavis-pharma-inc-ibuprofen-20-MG-ML-Oral-Suspens-336-USA-MPD"
    }
  ],
  "region": [
    {
      "coding": [
        {
          "code": "100000000557",
          "system": "https://spor.ema.europa.eu/v1/lists/100000000002",
          "display": "United States of America"
        }
      ]
    }
  ],
  "status": {
    "coding": [
      {
        "code": "200000017708",
        "system": "https://spor.ema.europa.eu/v1/lists/100000072049",
        "display": "Valid - Renewed/Varied"
      }
    ]
  },
  "holder": {
    "reference": "Organization/LOC-actavis-pharma-inc"
  }
}
